Amgen Inc. (AMGN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Amgen Inc. (AMGN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

AMGN Income Statement

Amgen Inc. (AMGN) annual income statement — 30-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	10.05B	8.62B	9.9B	9.56B	9.17B	8.15B	9.09B	8.5B	8.39B	7.45B	8.2B	6.9B	6.99B	6.11B	6.84B	6.65B	6.59B	6.24B	6.85B	6.71B
Revenue Growth %	9.68%	5.76%	8.91%	12.4%	9.29%	9.43%	10.86%	23.18%	20.07%	21.98%	19.84%	3.77%	5.94%	-2.13%	-0.1%	-0.81%	1.04%	5.71%	3.2%	4.41%
Cost of Goods Sold	2.81B	2.74B	1.79B	3.08B	3.01B	2.97B	3.11B	3.31B	3.24B	3.2B	3.11B	1.81B	1.81B	1.72B	1.75B	1.59B	1.51B	1.56B	1.72B	1.61B
COGS % of Revenue	27.96%	31.84%	18.09%	32.25%	32.85%	36.42%	34.25%	38.93%	38.58%	42.97%	37.97%	26.16%	25.95%	28.17%	25.54%	23.87%	22.9%	25.02%	25.09%	23.99%
Gross Profit	7.24B	5.87B	8.11B	6.47B	6.16B	5.18B	5.97B	5.19B	5.15B	4.25B	5.08B	5.1B	5.17B	4.38B	5.09B	5.06B	5.08B	4.68B	5.13B	5.1B
Gross Margin %	72.04%	68.16%	81.91%	67.75%	67.15%	63.58%	65.75%	61.07%	61.42%	57.03%	62.03%	73.84%	74.05%	71.83%	74.46%	76.13%	77.1%	74.98%	74.91%	76.01%
Gross Profit Growth %	17.66%	13.38%	35.69%	24.69%	19.49%	21.99%	17.51%	1.88%	-0.41%	-3.15%	-0.16%	0.65%	1.75%	-6.24%	-0.7%	-0.65%	3.99%	6.03%	1.81%	4.83%
Operating Expenses	3.73B	3.21B	4.16B	3.95B	3.51B	4B	3.66B	3.15B	3.24B	3.26B	3.81B	3.08B	2.49B	2.46B	2.86B	2.4B	2.91B	2.18B	2.82B	2.72B
OpEx % of Revenue	37.09%	37.22%	42.08%	41.32%	38.31%	49.12%	40.31%	37%	38.66%	43.72%	46.52%	44.56%	35.63%	40.36%	41.85%	36.14%	44.1%	34.9%	41.25%	40.55%
Selling, General & Admin	1.75B	1.6B	1.94B	1.72B	1.69B	1.69B	1.88B	1.63B	1.78B	1.81B	2.27B	1.35B	1.29B	1.26B	1.57B	1.29B	1.33B	1.23B	1.43B	1.3B
SG&A % of Revenue	17.36%	18.59%	19.57%	18%	18.45%	20.7%	20.67%	19.11%	21.28%	24.28%	27.75%	19.6%	18.52%	20.61%	22.99%	19.35%	20.12%	19.69%	20.82%	19.46%
Research & Development	1.87B	1.72B	2.15B	1.9B	1.74B	1.49B	1.72B	1.45B	1.45B	1.34B	1.53B	1.08B	1.11B	1.06B	1.32B	1.11B	1.04B	959M	1.35B	1.42B
R&D % of Revenue	18.58%	19.95%	21.74%	19.88%	19.02%	18.24%	18.97%	17.05%	17.25%	18.03%	18.72%	15.63%	15.93%	17.33%	19.36%	16.72%	15.76%	15.37%	19.69%	21.2%
Other Operating Expenses	1000K	-1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	-1000K	1000K	1000K	-1000K	1000K	-1000K
Operating Income	3.51B	2.67B	3.94B	2.53B	2.64B	1.18B	2.31B	2.05B	1.91B	991M	1.27B	2.02B	2.68B	1.92B	2.23B	2.66B	2.18B	2.5B	2.3B	2.38B
Operating Margin %	34.95%	30.94%	39.83%	26.43%	28.84%	14.46%	25.43%	24.07%	22.76%	13.31%	15.51%	29.28%	38.42%	31.47%	32.61%	39.99%	33%	40.08%	33.65%	35.46%
Operating Income Growth %	32.9%	126.32%	70.58%	23.4%	38.5%	18.87%	81.83%	1.29%	-28.87%	-48.41%	-43%	-24.02%	23.35%	-23.16%	-3.21%	11.86%	162.8%	17.43%	14.74%	-3.06%
EBITDA	3.44B	3.78B	5.07B	3.83B	3.98B	2.56B	3.71B	3.44B	3.31B	2.39B	2.65B	2.92B	3.58B	2.82B	3.14B	3.5B	3B	3.34B	3.16B	3.23B
EBITDA Margin %	34.23%	43.88%	51.27%	40.11%	43.47%	31.48%	40.81%	40.49%	39.45%	32.09%	32.34%	42.24%	51.25%	46.21%	45.93%	52.57%	45.56%	53.56%	46.1%	48.14%
EBITDA Growth %	-13.65%	47.45%	36.84%	11.33%	20.43%	7.32%	39.87%	18.07%	-7.57%	-15.28%	-15.6%	-16.61%	19.17%	-15.56%	-0.48%	8.33%	78.49%	12.49%	9.55%	-3.76%
D&A (Non-Cash Add-back)	0	1.12B	1.13B	1.31B	1.34B	1.39B	1.4B	1.4B	1.4B	1.4B	1.38B	895M	896M	900M	911M	837M	828M	841M	852M	850M
EBIT	3.44B	2.74B	2.17B	4.61B	2.28B	2.7B	1.53B	3.88B	1.6B	756M	1.67B	2.71B	2.37B	3.98B	2.16B	2.76B	1.86B	1.97B	2.47B	2.45B
Net Interest Income	-673M	-657M	-653M	-685M	-708M	-723M	-747M	-776M	-808M	-824M	-821M	-759M	-752M	-543M	-415M	-368M	-328M	-295M	-335M	-296M
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	673M	657M	653M	685M	708M	723M	747M	776M	808M	824M	821M	759M	752M	543M	415M	368M	328M	295M	335M	296M
Other Income/Expense	-746M	-582M	-2.43B	1.4B	-1.08B	795M	-1.53B	1.05B	-1.11B	-1.06B	-419M	-74M	-1.07B	1.52B	-482M	-268M	-645M	-825M	-173M	-223M
Pretax Income	2.77B	2.08B	1.51B	3.92B	1.57B	1.97B	782M	3.1B	794M	-68M	852M	1.95B	1.61B	3.44B	1.75B	2.39B	1.53B	1.68B	2.13B	2.15B
Pretax Margin %	27.53%	24.18%	15.3%	41.03%	17.1%	24.21%	8.61%	36.47%	9.47%	-0.91%	10.4%	28.21%	23.1%	56.38%	25.56%	35.96%	23.22%	26.85%	31.13%	32.14%
Income Tax	393M	265M	181M	705M	136M	243M	155M	271M	48M	45M	85M	217M	235M	601M	132M	249M	214M	199M	232M	271M
Effective Tax Rate %	14.2%	12.72%	11.96%	17.98%	8.67%	12.32%	19.82%	8.74%	6.05%	-66.18%	9.98%	11.15%	14.56%	17.46%	7.55%	10.41%	13.98%	11.88%	10.89%	12.58%
Net Income	2.38B	1.82B	1.33B	3.22B	1.43B	1.73B	627M	2.83B	746M	-113M	767M	1.73B	1.38B	2.84B	1.62B	2.14B	1.32B	1.48B	1.9B	1.88B
Net Margin %	23.62%	21.11%	13.47%	33.65%	15.62%	21.23%	6.9%	33.28%	8.89%	-1.52%	9.36%	25.06%	19.74%	46.54%	23.63%	32.22%	19.97%	23.66%	27.74%	28.09%
Net Income Growth %	65.85%	5.14%	112.6%	13.64%	91.96%	1630.97%	-18.25%	63.58%	-45.9%	-103.98%	-52.54%	-19.27%	4.71%	92.48%	-14.9%	13.75%	183.84%	-10.33%	17.59%	-6.78%
Net Income (Continuing)	2.38B	1.82B	1.33B	3.22B	1.43B	1.73B	627M	2.83B	746M	-113M	767M	1.73B	1.38B	2.84B	1.62B	2.14B	1.32B	1.48B	1.9B	1.88B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	4.37	3.34	2.45	5.93	2.65	3.20	1.16	5.22	1.38	-0.21	1.42	3.22	2.57	5.28	3.00	3.98	2.45	2.68	3.36	3.31
EPS Growth %	64.91%	4.38%	111.21%	13.6%	92.03%	1623.81%	-18.31%	62.11%	-46.3%	-103.98%	-52.67%	-19.1%	4.9%	97.01%	-10.71%	20.24%	202.47%	-5.3%	21.74%	-3.5%
EPS (Basic)	4.40	3.37	2.47	5.98	2.66	3.22	1.17	5.27	1.39	-0.21	1.43	3.23	2.58	5.32	3.02	4.01	2.46	2.69	3.38	3.32
Diluted Shares Outstanding	544M	544M	543M	542M	541M	541M	542M	542M	541M	536M	540M	538M	537M	538M	539M	538M	537M	551M	565M	570M
Basic Shares Outstanding	540M	540M	539M	538M	538M	538M	540.52M	537M	537M	536M	535M	535M	535M	534M	535M	535M	535M	548M	562M	567M
Dividend Payout Ratio	57.35%	74.66%	96.25%	39.86%	89.39%	73.93%	192.19%	42.76%	162.06%	-	148.63%	65.9%	82.6%	40.02%	64.36%	48.44%	78.82%	73.17%	52.13%	53.03%